Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-25 @ 12:26 AM
NCT ID:
NCT01719367
Eligibility Criteria:
Inclusion Criteria:
* Subjects must be at least 18 years of age.
* Subjects must have a history of persistent AF currently treated with a rate control strategy.
* Subjects should be willing to give written, informed consent.
* Subjects must be willing and able to participate in the exercise protocol.
Exclusion Criteria:
* New York Heart Association Class III or IV heart failure.
* A history of heart failure induced by tachy-arrhythmia.
* A history of coronary artery disease and the presence of at least one of the following:
* Canadian Class III or IV angina.
* Recent myocardial infarction, coronary artery bypass grafting, or percutaneous coronary intervention within 6 months.
* Severe renal or hepatic impairment.
* Subjects who have a clinically significant allergy/intolerance to atenolol, including a history of beta-blocker induced bronchospasm.
* Females who are pregnant or nursing.
* History of severe AV node dysfunction/pacemaker dependence.
* Subjects who have a systolic blood pressure \< 90 mm Hg or resting Ventricular Rate \<50 or \>120 per minute on the day of the study.
* Patients currently taking Vaughan-Williams Class I or III anti-arrhythmic drugs.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01719367
Study Brief:
Protocol Section:
NCT01719367